Mixed Fortunes: London Stock Markets React to Trade Deal
London's stock indexes had a mixed performance due to corporate updates and a new U.S.-EU trade deal. The FTSE 100 rose, driven by healthcare stocks, while the FTSE 250 fell. Key movements included AstraZeneca's rise, Croda International's fall, and significant changes in companies like Games Workshop and Inchcape.
London's stock markets exhibited mixed performance on Tuesday, influenced by varying corporate updates and the ramifications of a newly signed trade agreement between the U.S. and EU.
The FTSE 100 index increased by 0.4% by 0934 GMT, with healthcare stocks leading the way. AstraZeneca notably surged 2.8% after surpassing Q2 revenue and profit forecasts.
However, chemical stocks were down 2.5%, largely due to Croda International's 5.1% decline following underwhelming first-half sales. Additionally, industrial miners were impacted by lower copper prices, affecting companies like Glencore and Anglo American.
(With inputs from agencies.)
Advertisement
ALSO READ
AstraZeneca's Bold Move: $50 Billion US Investment Amidst Pharma Tariff Challenges
AstraZeneca's Revenue Surge Amid U.S. Market Push
AstraZeneca's Strategic U.S. Expansion Amid Price-Cutting Moves
AstraZeneca Thrives Amid Global Challenges, Eyes U.S. Expansion
AstraZeneca Overcomes Barriers with Strong Sales and Strategic Investments
Google News